HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Endocrine Gland Neoplasms (Cancer, Endocrine)

Subscribe to New Research on Endocrine Gland Neoplasms

Tumors or cancer of the ENDOCRINE GLANDS.

Also Known As:

Cancer, Endocrine; Endocrine Cancer; Cancer of the Endocrine Gland; Carcinoma of Endocrine Gland; Endocrine Gland Carcinoma; Neoplasms, Endocrine Gland; Cancer, Endocrine Gland; Cancers, Endocrine; Carcinoma, Endocrine Gland; Endocrine Cancers; Endocrine Gland Neoplasm; Neoplasm, Endocrine Gland; Cancer of Endocrine Gland; Endocrine Gland Cancer

Networked: 68 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Neoplasms (Cancer)
2.	Thyroid Neoplasms (Thyroid Cancer)
3.	Breast Neoplasms (Breast Cancer)
4.	Neoplasm Metastasis (Metastasis)
5.	Multiple Endocrine Neoplasia Type 2b (MEN 3)

Experts

1.	Schott, Matthias: 3 articles (09/2006 - 12/2002)
2.	Baudin, Eric: 2 articles (04/2015 - 01/2014)
3.	Schulte, Klaus-Martin: 2 articles (07/2012 - 01/2012)
4.	Seissler, Jochen: 2 articles (05/2003 - 12/2002)
5.	Lew, John I: 1 article (06/2015)
6.	Block, Norman L: 1 article (06/2015)
7.	Rick, Ferenc G: 1 article (06/2015)
8.	Schally, Andrew V: 1 article (06/2015)
9.	Elliot, Sharon J: 1 article (06/2015)
10.	Catanuto, Paola: 1 article (06/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Endocrine Gland Neoplasms:

1.	HormonesIBA 11/01/2008 - "The contribution of defects in the normal transmission of hormone-dependent signals to the development of endocrine cancers has been widely analyzed and the knowledge derived from these studies has allowed us to develop many successful therapeutic strategies. " 12/01/1983 - "Conceptually, such absence of adjunctive hormone effect on survival time after operation is similar to hormonal effects in other endocrine cancers, which may nevertheless provide good palliation in some cases." 12/01/2002 - "This is the first study to show that a polypeptide hormone can be used to develop a DC vaccination strategy for the immunotherapy of highly malignant endocrine cancers." 09/01/2010 - "The ectopic hormone production by tumor cells that have a light optical structure of typical non-endocrine cancers has long attracted the attention of investigation all over the world. " 06/01/2009 - "Whilst for ER-positive cancers, endocrine therapy is highly successful in the adjuvant setting, a significant proportion of cancers exhibit hormone resistance, often associated with altered growth factor receptor or ER signalling. "
2.	MelatoninIBA 09/01/1995 - "Recent experiments suggest the possibility of modulating the efficacy of cancer endocrine therapy by the pineal hormone melatonin (MLT). " 04/01/1995 - "Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone." 04/01/2012 - "Strong reductions of circulating melatonin are also observed in numerous disorders and diseases, including Alzheimer's disease, various other neurological and stressful conditions, pain, cardiovascular diseases, cases of cancer, endocrine and metabolic disorders, in particular diabetes type 2. The significance of melatonergic signaling is also evident from melatonin receptor polymorphisms associated with several of these pathologies. "
3.	imatinib (Gleevec)FDA Link 01/01/2014 - "We therefore sought to establish a safe, novel treatment regimen combining imatinib with cytotoxic chemotherapy for future study in endocrine cancers. " 01/01/2014 - "A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers."
4.	LeptinIBA 01/01/2011 - "Considering that thyroid cancer is the most common endocrine cancer, the aim of this study was evaluation of leptin levels in thyroid cancer. "
5.	Tamoxifen FDA LinkGeneric 04/01/1995 - "Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone."
6.	Dacarbazine (DIC)FDA LinkGeneric 01/01/2014 - "A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers."
7.	enzastaurinIBA 08/01/2011 - "In this study, we investigate the effects of a PKC inhibitor, Enzastaurin, in human pancreatic neuroendocrine neoplasms (PNN) primary cultures and in the human pancreatic endocrine cancer cell line, BON1. "
8.	capecitabine (Xeloda)FDA Link 01/01/2014 - "A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers."
9.	Factor IX (PTC)FDA LinkGeneric 06/01/2015 - "Papillary thyroid cancer (PTC) is the most prevalent of all endocrine cancers. " 01/01/2015 - "Papillary Thyroid Cancer (PTC) is the most prevalent type of endocrine cancer. " 07/01/2012 - "Papillary thyroid cancer (PTC) is a common endocrine cancer and frequently presents with lymph node (LN) metastases. " 01/01/2012 - "Papillary thyroid cancer (PTC) is a common endocrine cancer and commonly presents with lymph node (LN) metastases. " 12/01/2008 - "The papillary thyroid carcinoma (PTC) is the most frequent endocrine cancer and it is the most common thyroid cancer (85-95%). "
10.	papillary Thyroid cancerIBA 06/01/2015 - "Papillary thyroid cancer (PTC) is the most prevalent of all endocrine cancers. " 01/01/2015 - "Papillary Thyroid Cancer (PTC) is the most prevalent type of endocrine cancer. " 07/01/2012 - "Papillary thyroid cancer (PTC) is a common endocrine cancer and frequently presents with lymph node (LN) metastases. " 01/01/2012 - "Papillary thyroid cancer (PTC) is a common endocrine cancer and commonly presents with lymph node (LN) metastases. " 12/01/2008 - "The papillary thyroid carcinoma (PTC) is the most frequent endocrine cancer and it is the most common thyroid cancer (85-95%). "

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 06/01/2013 - "Treatment of advanced forms of endocrine cancer which are not responsive to cytotoxic chemotherapies is challenging and use of KIs is gaining a growing role in this field. " 12/01/2010 - "For endocrine cancers that are no longer localized, current modes of therapy, including various combinations of chemotherapy and radiation, are inadequate, posing a major challenge to ongoing research to develop more effective methods for diagnosis and treatment. " 02/01/2002 - "More and more data are being accumulated suggesting that these preparations could, in the near future, be used in the pharmacotherapy of some endocrine gland neoplasms." 01/01/2014 - "We therefore sought to establish a safe, novel treatment regimen combining imatinib with cytotoxic chemotherapy for future study in endocrine cancers. " 05/01/2003 - "Preliminary results suggest that DC vaccines might be novel tools for antitumour immunotherapies to treat chemotherapy-resistant and radioresistant endocrine cancers, such as metastasized medullary thyroid carcinomas and other neuroendocrine carcinomas."
2.	Immunotherapy 09/01/2006 - "Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers." 12/01/2002 - "This is the first study to show that a polypeptide hormone can be used to develop a DC vaccination strategy for the immunotherapy of highly malignant endocrine cancers." 05/01/2003 - "Preliminary results suggest that DC vaccines might be novel tools for antitumour immunotherapies to treat chemotherapy-resistant and radioresistant endocrine cancers, such as metastasized medullary thyroid carcinomas and other neuroendocrine carcinomas."
3.	Bariatric Surgery 09/01/2004 - "Bariatric surgery patients had significant risk reductions for developing cardiovascular, cancer, endocrine, infectious, psychiatric, and mental disorders compared with controls, with the exception of hematologic (no difference) and digestive diseases (increased rates in the bariatric cohort). "
4.	Liver Transplantation 09/01/2003 - "Because of dismal mid-term and long-term results, secondary liver cancer is considered an absolute contra-indication to cadaveric liver transplantation, with the relative exception of metastases of symptomatic neuro-endocrine cancers. "